Auph short interest.

Artal Group S.A. increased its stake in shares of Kymera Therapeutics, Inc. (NASDAQ:KYMR – Get Rating) by 33.3% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 2,000,000 shares of the company’s stock after buying an additional 500,000 …Web1K subscribers in the AUPH community. A place to discuss Aurinia Pharmaceuticals, Inc.This page provides short interest, short volume, short volume ratio, short borrow rates, and short squeeze score for the security. US: AUPH / Aurinia Pharmaceuticals Inc - Insider Trading Report This page provides data on the corporate insiders of Aurinia Pharmaceuticals Inc and their trades, trade performance, and predictive analysis. The Short Squeeze Score is the result of a sophisticated, multi-factor quantitative model that identifies companies that have the highest risk of experiencing a short squeeze. The scoring model uses a combination of short interest, float, short borrow fee rates, and other metrics. The number ranges from 0 to 100, with higher numbers indicating ... 2023-03-14 Short sale volume (not short interest) for $AUPH is 32%. http://shortvolumes.com/?t=AUPH $XLV 48% $AEZS 50% $REGN 54%. 16 Mar 2023 00:36:01Web

In today’s fast-paced world, expressing gratitude has become more important than ever. A short thank you note is a wonderful way to show appreciation and make someone feel valued. Expressing gratitude is not only polite but also has numerou...Nov 6, 2022 · AUPH has a market cap of $1.08bn and $400 million of cash, cash equivalents, restricted cash and investments as of October 31, 2022. In the previous quarter, the company made $55mn in revenue ...

Aurinia Pharmaceuticals ( NASDAQ: AUPH) named Dr. Robert Foster as a new board member Thursday as part of an agreement with its major shareholder and investment management firm, MKT Capital Ltd ...

Aug 2, 2023 · Aurinia Pharma (AUPH) is scheduled to announce Q2 earnings results on Thursday, August 3rd, before market open.The consensus EPS Estimate is -$0.18 (+28.0% Y/Y) and the consensus... M&A season started some weeks ago with Trilium / Pfizer, Sanofi bought Kadmon, etc... AUPH is one of the best candidate for the big pharmas. A weird Press Release appeared a couple of weeks ago on different websites, about a 35+ acquisition by a big pharma, it was later asked to be removed by the company from Benzinga. The short interestAt the end of Q2 2019, Aurinia had cash, cash equivalents and short-term investments of $150.2 million. Net cash used in operating activities was $12.3 million for Q2 2018 compared to $14.0 ...Jul 4, 2022 · Still, when we talk about a small-cap biotech that is clearly drawing the interest of some big pharma guys, we can say that AUPH's current valuation is very low, without but surely with buyout ... Aug 24, 2022 · Approximately 10% of the overall float is currently held short. Two directors bought a collective 10,000 shares in early March. Prior to that several insiders sold just over $1.2 million worth of ...

Aurinia Pharma ( NASDAQ: AUPH) is scheduled to announce Q3 earnings results on Thursday, November 2nd, before market open. The consensus EPS Estimate is -$0.17 vs -$0.06 in 3Q22 and the consensus ...

The forecasted annual EBITDA of AUPH / Aurinia Pharmaceuticals Inc in 2025-12-31 is -52MM. EBIDTA is an acronym that stands for earnings before interest, taxes, depreciation, and amortization. Analysts and investors pay attention to EBITDA because it strips out items that a company must report on its balance sheet but doesn’t significantly ...

316 K. 119 K. +166%. Loading... Stock Performance by Trading Session. Trading Session Volume Relative to Daily Average. View statistical stock analysis for Aurinia Pharmaceuticals - Common Shares (AUPH). Choose from a list of different historical perspectives such as intraday stock behavior, gap up moves, gap down moves, large …WebAUPH Short Interest Back to AUPH Overview NASDAQ, Inc. short interest is available by issuer for the past 12 months and updated twice a month. Short interest data is reported on... Aurinia Pharmaceuticals (AUPH +4.4%) is trading higher after its Chief Executive Officer Peter Greenleaf hinted at strong sales for the company as the management prepares to release the financials ...In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in AUPH / Aurinia Pharmaceuticals Inc. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. We would like to show you a description here but the site won’t allow us.

Back to AUPH Overview. NASDAQ, Inc. short interest is available by issuer for the past 12 months and updated twice a month. Short interest data is reported on …are three bearish stocks that you should think about shorting this week, writes technical analyst Bob Lang in his latest edition of Bearish Bets....TSM Each week we identify names that look bearish and may present interesting investing oppo...Jun 30, 2023 · Based on recent acquisitions, Aurinia ( AUPH) would be more likely to see $18–$20 per share in a takeover, RBC analyst Douglas Miehm, who has an outperform rating with a $13 price target on AUPH ... Arrow Financial Co. (NASDAQ:AROW – Get Rating) was the recipient of a significant increase in short interest during the month of March. As of March 15th, there was short interest totalling 153,000 shares, an increase of 13.1% from the February 28th total of 135,300 shares. Based on an average trading volume of 34,700 shares, the […]WebIn an ideal world, we would all find a way to make our money that is sitting in our banks work for us rather than, well, just sit there. One of the ways we can do that is by placing our money in accounts that offer a decent Annual Percentag...AUPH short interest is 12%. More on Aurinia. Aurinia Pharmaceuticals: Some Improvement In Topline, But A Buyout Alone Will Unlock Value; Aurinia Pharmaceuticals: All In On Lupkynis - A Tough Bet;

Track Aurinia Pharmaceuticals Inc (AUPH) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors

The Short Squeeze Score is the result of a sophisticated, multi-factor quantitative model that identifies companies that have the highest risk of experiencing a short squeeze. The scoring model uses a combination of short interest, float, short borrow fee rates, and other metrics. The number ranges from 0 to 100, with higher numbers indicating ... The short story “Checkouts” by children and teen author Cynthia Rylant is about the games people play with each other and with themselves when they are interested in someone and do not know how to show it.AUPH Short Interest Back to AUPH Overview NASDAQ, Inc. short interest is available by issuer for the past 12 months and updated twice a month. Short interest data is reported on... 316 K. 119 K. +166%. Loading... Stock Performance by Trading Session. Trading Session Volume Relative to Daily Average. View statistical stock analysis for Aurinia Pharmaceuticals - Common Shares (AUPH). Choose from a list of different historical perspectives such as intraday stock behavior, gap up moves, gap down moves, large …WebShort Float / Ratio: 13.17% / 8.88: Perf Quarter-4.23%: Sales: 158.85M: P/S: 8.19: EPS this Y: 31.36%: Inst Trans: 9.16%: Short Interest: 17.19M: Perf Half Y-5.03%: Book/sh: 2.73: P/B: 3.32: EPS next Y: 29.71%: ROA-14.80%: Target Price: 13.21: Perf Year: 76.61%: Cash/sh: 2.35: P/C: 3.85: EPS next 5Y-ROE-18.94%: 52W Range: 4.07 - 12.43: Perf YTD ...AUPH 4.86%. Apple Inc. $191.24. AAPL 0.68%. Sarepta Therapeutics Inc. ... Earnings before interest, taxes, depreciation, and amortization, is a measure of a company's overall financial performance ...A high-level overview of Aurinia Pharmaceuticals Inc. (AUPH) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. ... Short Interest ...Mar 7, 2022 · The actual guidance provided by AUPH in its earnings release on Feb 28, fell way short of that Wall St number: "For fiscal year 2022, the Company is providing net revenue guidance of $115 to $135 ... The largest shareholder of Aurinia Pharmaceuticals ( NASDAQ: AUPH) said it plans to withholder support for seven board members at the company's upcoming annual meeting. Iljin SNT, which has a 6.1% ...Mar 21, 2023 · Biotech stocks are very interest rate sensitive and I suspect once the Federal Reserve pivots and begins cutting interest rates, AUPH and the rest of the sector's stocks will move materially ...

Amount of cash a business has after it has met its financial obligations such as debt and outstanding payments. -25.98M. -347.29%. Get the latest Ardelyx Inc (ARDX) real-time quote, historical ...Web

Introduction. This short interest tracker provides a variety of short interest related data, sourced from a variety of partners. The data is organized by frequency of updates, with intraday data at the top (short shares availability, short borrow fee rate), daily data (short volume, fails-to-deliver) in the middle, and the slowest updated data (short interest) at …

Aurinia ( AUPH) shares have climbed ~59.7% in the year so far despite a ~2% decline over the past 30 days. The stock has added ~5.8% in the post-market with ~1.5M shares changing hands compared to ...In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in AUPH / Aurinia Pharmaceuticals Inc. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. Aurinia Pharma (AUPH) is scheduled to announce Q2 earnings results on Thursday, August 3rd, before market open.The consensus EPS Estimate is -$0.18 (+28.0% Y/Y) and the consensus...That beat AUPH stock analysts' estimate for $22 million, according to FactSet. Per-share losses were 25 cents, narrower than expectations for 27 cents. Still, AUPH stock fell to its lowest point ...Web1K subscribers in the AUPH community. A place to discuss Aurinia Pharmaceuticals, Inc. Coins. 0 coins. Premium Powerups Explore Gaming. Valheim Genshin Impact Minecraft Pokimane Halo Infinite Call of Duty: Warzone Path of Exile Hollow Knight: Silksong Escape from Tarkov Watch Dogs: Legion. Sports ...AUPH Short Interest Back to AUPH Overview NASDAQ, Inc. short interest is available by issuer for the past 12 months and updated twice a month. Short interest data is reported on...Jul 7, 2023 · NP. VQNPX - Vanguard Growth and Income Fund Investor Shares This fund is a listed as child fund of Vanguard Group Inc and if that institution has disclosed ownership in this security, then these positions will not be double counted when calculating total shares and total value. 28,200. -40.63. Short Interest. Percentage of Shares Shorted 6.91% of the float of ESSA Pharma has been sold short. Short Interest Ratio / Days to Cover ESSA Pharma has a short interest ratio ("days to cover") of 7.8. Change versus previous month Short interest in ESSA Pharma has recently increased by 1.47%, indicating that investor sentiment is …Web

A short bio should include an introduction, information about education, relevant information regarding awards and achievements, and a conclusion. Depending on the purpose of the bio, it may also include relevant work experience and qualifi...Nov 21, 2023 · Aurinia Pharmaceuticals (AUPH) Short Interest Ratio & Short Volume $8.85 -0.39 (-4.22%) (As of 03:22 PM ET) Compare Today's Range $8.77 $10.05 50-Day Range $7.13 $9.24 52-Week Range $4.07 $12.43 Volume 6.25 million shs Average Volume 2.60 million shs Market Capitalization $1.27 billion P/E Ratio N/A Dividend Yield N/A Price Target $14.00 AUPH short interest is 12%. More on Aurinia. Aurinia Pharmaceuticals: Some Improvement In Topline, But A Buyout Alone Will Unlock Value; Aurinia Pharmaceuticals: All In On Lupkynis - A Tough Bet;The actual guidance provided by AUPH in its earnings release on Feb 28, fell way short of that Wall St number: "For fiscal year 2022, the Company is providing net revenue guidance of $115 to $135 ...Instagram:https://instagram. cola 2024 increasechase refi mortgage ratescaccblueowl stock On today's stock market, AUPH stock toppled 9.4% to 10.49. The hirings likely cooled investors' expectations that Aurinia could be looking for a buyout. In late 2021, reports suggested Bristol ...Web air industries groupcan you use a credit card to buy stocks 316 K. 119 K. +166%. Loading... Stock Performance by Trading Session. Trading Session Volume Relative to Daily Average. View statistical stock analysis for Aurinia Pharmaceuticals - Common Shares (AUPH). Choose from a list of different historical perspectives such as intraday stock behavior, gap up moves, gap down moves, large …Web momentum investing AUPH Short Interest Back to AUPH Overview NASDAQ, Inc. short interest is available by issuer for the past 12 months and updated twice a month. Short interest data is reported on...Aurinia Pharma (AUPH) is scheduled to announce Q2 earnings results on Thursday, August 3rd, before market open.The consensus EPS Estimate is -$0.18 (+28.0% Y/Y) and the consensus...Short interest, stock short squeeze, short interest ratio & short selling data positions for NASDAQ, NYSE & AMEX stocks to find shorts in the stock market.Web